Umstead John W. V 4
4 · G1 Therapeutics, Inc. · Filed Mar 22, 2024
Insider Transaction Report
Form 4
Umstead John V.
Chief Financial Officer
Transactions
- Award
Common Stock
2024-03-20+37,500→ 161,396 total
Footnotes (3)
- [F1]Represents a restricted stock unit ("RSU") award that vests 50% on March 20, 2025 and 50% on March 20, 2026, subject to the Reporting Person's continued service through each applicable vesting date.
- [F2]Each RSU represents a contingent right to receive one share of Issuer common stock.
- [F3]Represents (i) 9,421 shares of common stock; (ii) 425 RSUs from award granted on January 4, 2021; (iii) 2,000 RSUs from award granted on January 3, 2022; (iv) 2,250 RSUs from award granted on January 3, 2023; (v) 37,500 RSUs from award granted on March 15, 2023; (vi) 35,000 RSUs from award granted on May 10, 2023; (vii) 37,300 RSU's granted on January 3, 2024; and (viii) 37,500 RSU's from award granted on March 20, 2024.